Vaxcyte Inc (NASDAQ: PCVX) is 63.54% higher on its value in year-to-date trading and has touched a low of $46.16 and a high of $121.06 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PCVX stock was last observed hovering at around $104.07 in the last trading session, with the day’s loss setting it -1.37%.
Currently trading at $102.70, the stock is -7.33% and -7.48% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.2 million and changing -1.32% at the moment leaves the stock 25.23% off its SMA200. PCVX registered 104.38% gain for a year compared to 6-month gain of 56.63%. The firm has a 50-day simple moving average (SMA 50) of $110.5236 and a 200-day simple moving average (SMA200) of $81.81145.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -8.20% loss in the last 1 month and extending the period to 3 months gives it a 31.85%, and is -3.43% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.11% over the week and 3.82% over the month.
Vaxcyte Inc (PCVX) has around 254 employees, a market worth around $12.80B and $0.00M in sales. Distance from 52-week low is 122.49% and -15.16% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.77%).
The EPS is expected to grow by 5.82% this year
391.0 institutions hold shares in Vaxcyte Inc (PCVX), with institutional investors hold 102.08% of the company’s shares. The shares outstanding are 121.80M, and float is at 117.28M with Short Float at 7.97%. Institutions hold 101.59% of the Float.
The top institutional shareholder in the company is FMR LLC with over 16.17 million shares valued at $1.22 billion. The investor’s holdings represent 13.788 of the PCVX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 9.94 million shares valued at $750.56 million to account for 8.477 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 9.8 million shares representing 8.3552 and valued at over $739.77 million, while JANUS HENDERSON GROUP PLC holds 7.5637 of the shares totaling 8.87 million with a market value of $669.72 million.
Vaxcyte Inc (PCVX) Insider Activity
Vaxcyte Inc disclosed in a document filed with the SEC on Nov 05 ’24 that Eydelman Mikhail (SVP, GEN COUNSEL & CORP SEC) sold a total of 5,000 shares of the company’s common stock. The trade occurred on Nov 05 ’24 and was made at $106.36 per share for $0.53 million. Following the transaction, the insider now directly holds 28623.0 shares of the PCVX stock.
Still, SEC filings show that on Nov 05 ’24, Eydelman Mikhail (Officer) Proposed Sale 5,000 shares at an average price of $105.18 for $0.53 million. The insider now directly holds shares of Vaxcyte Inc (PCVX).
